ALPINE Study
Investigator
Meeting

We are pleased to invite you to the ALPINE Investigator Meeting on July 10–11 in Chicago, Illinois at the Four Seasons Chicago.

The meeting is designed to be high value for both investigators and coordinators and will feel very different than typical investigator meetings for pharma-sponsored studies.  The meeting sessions will be scientifically and clinically oriented rather than administrative/clerical in nature, focusing on LPP disease biology, scientific rationale for brepocitinib in LPP, and practical strategies for patient selection, recruitment, and high-quality trial execution.  All sessions will be led by clinical/scientific experts in LPP and/or JAK-STAT biology, or Priovant (sponsor) executives. 

Unlike many medical dermatology indications like atopic dermatitis, psoriasis, or HS, there is limited precedent for multi-center placebo-controlled trials in LPP.  We believe the IM can be an important forum to bring together study teams from around the world for a focused discussion that can help set this study up for success, and we hope you will consider carving out time from your busy schedule to join.

Registration for the ALPINE Study Investigator Meeting is due by Friday, June 5. If you have any questions regarding this meeting, please contact Whitney Holmes at whitney.holmes@priovant.com.